| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.067 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |